Karmanos Cancer Institute (Site 070) — Detroit, Michigan

Karmanos Cancer Institute (Site 070) is a clinical research site located in Detroit, Michigan, United States 48201.

Crixeo Health Trust Score: 47/100 (POOR). This profile has not yet been claimed by the site owner.

Karmanos Cancer Institute (Site 070) has participated in 1 clinical trials.

Therapeutic areas: Non-small Cell Lung Cancer, Lung Cancer, Advanced Malignancies.

Sponsors: Ariad Pharmaceuticals.

Sponsor Feasibility Report

Trust Score: 47/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Karmanos Cancer Institute (Site 070)?

Karmanos Cancer Institute (Site 070) has a Crixeo Trust Score of 47/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Karmanos Cancer Institute (Site 070) conducted?

Karmanos Cancer Institute (Site 070) has 1 clinical trials on record. Their work covers Non-small Cell Lung Cancer, Lung Cancer, Advanced Malignancies.

Is Karmanos Cancer Institute (Site 070) accredited by Crixeo Health?

Karmanos Cancer Institute (Site 070) has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Karmanos Cancer Institute (Site 070)?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.